Geron Non Operating Income Net Other from 2010 to 2026

GERN Stock  USD 1.66  0.01  0.61%   
Geron Non Operating Income Net Other yearly trend continues to be very stable with very little volatility. Non Operating Income Net Other is likely to grow to about 4.3 M this year. During the period from 2010 to 2026, Geron Non Operating Income Net Other quarterly data regression pattern had sample variance of 3.1 T and median of  1,996,000. View All Fundamentals
 
Non Operating Income Net Other  
First Reported
2011-06-30
Previous Quarter
1.3 M
Current Value
3.9 M
Quarterly Volatility
721.6 K
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Geron financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Geron's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 22.3 M or Selling General Administrative of 176 M, as well as many indicators such as Price To Sales Ratio of 4.55, Dividend Yield of 0.0 or PTB Ratio of 2.99. Geron financial statements analysis is a perfect complement when working with Geron Valuation or Volatility modules.
  
Build AI portfolio with Geron Stock
Check out the analysis of Geron Correlation against competitors.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
Evaluating Geron's Non Operating Income Net Other across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Geron's fundamental strength.

Latest Geron's Non Operating Income Net Other Growth Pattern

Below is the plot of the Non Operating Income Net Other of Geron over the last few years. It is Geron's Non Operating Income Net Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Geron's overall financial position and show how it may be relating to other accounts over time.
Non Operating Income Net Other10 Years Trend
Slightly volatile
   Non Operating Income Net Other   
       Timeline  

Geron Non Operating Income Net Other Regression Statistics

Arithmetic Mean2,040,843
Geometric Mean1,866,407
Coefficient Of Variation86.62
Mean Deviation1,500,775
Median1,996,000
Standard Deviation1,767,826
Sample Variance3.1T
Range5.4M
R-Value0.82
Mean Square Error1.1T
R-Squared0.68
Significance0.000049
Slope288,167
Total Sum of Squares50T

Geron Non Operating Income Net Other History

20264.3 M
20254.1 M
20223.5 M
20211.6 M
2020M
20194.2 M
20183.1 M

About Geron Financial Statements

Geron investors utilize fundamental indicators, such as Non Operating Income Net Other, to predict how Geron Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Non Operating Income Net Other4.1 M4.3 M

Pair Trading with Geron

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Geron position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Geron will appreciate offsetting losses from the drop in the long position's value.

Moving together with Geron Stock

  0.82EQ EquilliumPairCorr

Moving against Geron Stock

  0.85OSE OSE Pharma SAPairCorr
  0.8VCYT VeracytePairCorr
  0.75RAC Race OncologyPairCorr
  0.37VANI Vivani MedicalPairCorr
  0.36OB3 OPTIBIOTIX HLTH PLCPairCorr
The ability to find closely correlated positions to Geron could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Geron when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Geron - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Geron to buy it.
The correlation of Geron is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Geron moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Geron moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Geron can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:
Check out the analysis of Geron Correlation against competitors.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Will Biotechnology sector continue expanding? Could Geron diversify its offerings? Factors like these will boost the valuation of Geron. Market participants price Geron higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Geron data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.12)
Revenue Per Share
0.275
Quarterly Revenue Growth
0.671
Return On Assets
(0.08)
Return On Equity
(0.30)
Understanding Geron requires distinguishing between market price and book value, where the latter reflects Geron's accounting equity. The concept of intrinsic value - what Geron's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Geron's price substantially above or below its fundamental value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Geron's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.